A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer
GlaxoSmithKline
GlaxoSmithKline
Immunitas Therapeutics
AVM Biotechnology Inc
MultiVir, Inc.
Amgen
Incyte Corporation
Valerio Therapeutics
INSYS Therapeutics Inc